Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 16 | 2025 | 976 | 2.850 |
Why?
|
| HIV-1 | 13 | 2025 | 725 | 1.630 |
Why?
|
| Membrane Proteins | 8 | 2017 | 909 | 1.250 |
Why?
|
| CD8-Positive T-Lymphocytes | 9 | 2025 | 679 | 1.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 8 | 2025 | 645 | 1.010 |
Why?
|
| Simian Immunodeficiency Virus | 3 | 2024 | 81 | 1.000 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 3 | 2024 | 59 | 0.940 |
Why?
|
| Disease Reservoirs | 1 | 2025 | 10 | 0.940 |
Why?
|
| Myeloid Cells | 1 | 2025 | 94 | 0.890 |
Why?
|
| Killer Cells, Natural | 3 | 2024 | 219 | 0.850 |
Why?
|
| Macrophages | 2 | 2021 | 1053 | 0.820 |
Why?
|
| Central Nervous System | 1 | 2025 | 197 | 0.800 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2024 | 147 | 0.710 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2025 | 182 | 0.580 |
Why?
|
| Cytokines | 3 | 2021 | 945 | 0.570 |
Why?
|
| Virus Latency | 3 | 2025 | 32 | 0.500 |
Why?
|
| Biomarkers | 3 | 2020 | 1431 | 0.500 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 8 | 2017 | 15 | 0.470 |
Why?
|
| Plasma | 1 | 2015 | 38 | 0.440 |
Why?
|
| ADAM Proteins | 1 | 2015 | 32 | 0.440 |
Why?
|
| Cell Proliferation | 3 | 2017 | 1002 | 0.440 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2015 | 77 | 0.440 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2013 | 47 | 0.410 |
Why?
|
| Synapses | 1 | 2013 | 191 | 0.360 |
Why?
|
| Viral Load | 3 | 2024 | 233 | 0.320 |
Why?
|
| Lymphocyte Activation | 4 | 2024 | 761 | 0.310 |
Why?
|
| Macaca mulatta | 3 | 2024 | 256 | 0.250 |
Why?
|
| Coronavirus | 2 | 2023 | 14 | 0.250 |
Why?
|
| Immune Evasion | 2 | 2025 | 68 | 0.240 |
Why?
|
| Humans | 23 | 2025 | 64283 | 0.240 |
Why?
|
| Flow Cytometry | 3 | 2024 | 668 | 0.230 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2025 | 15 | 0.230 |
Why?
|
| Virus Activation | 1 | 2024 | 24 | 0.220 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2024 | 5 | 0.220 |
Why?
|
| GPI-Linked Proteins | 1 | 2024 | 40 | 0.210 |
Why?
|
| Herpesvirus 6, Human | 1 | 2024 | 18 | 0.210 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2018 | 151 | 0.210 |
Why?
|
| Harmine | 1 | 2023 | 2 | 0.210 |
Why?
|
| Hepacivirus | 2 | 2018 | 140 | 0.200 |
Why?
|
| HIV Antibodies | 2 | 2021 | 148 | 0.190 |
Why?
|
| Antibodies, Neutralizing | 2 | 2020 | 214 | 0.180 |
Why?
|
| Animals | 8 | 2025 | 20967 | 0.180 |
Why?
|
| Antigens, CD | 2 | 2014 | 348 | 0.170 |
Why?
|
| Cells, Cultured | 5 | 2018 | 2177 | 0.170 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2021 | 29 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2023 | 329 | 0.160 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2020 | 24 | 0.160 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 13 | 1 | 2020 | 2 | 0.160 |
Why?
|
| B-Cell Activating Factor | 1 | 2020 | 9 | 0.160 |
Why?
|
| Microfluidics | 1 | 2020 | 25 | 0.160 |
Why?
|
| CD40 Ligand | 1 | 2020 | 159 | 0.160 |
Why?
|
| Immunity, Mucosal | 1 | 2020 | 52 | 0.160 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 2238 | 0.160 |
Why?
|
| AIDS Vaccines | 1 | 2020 | 72 | 0.150 |
Why?
|
| T-Lymphocytes | 2 | 2014 | 1019 | 0.150 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2020 | 60 | 0.150 |
Why?
|
| Signal Transduction | 4 | 2017 | 3070 | 0.140 |
Why?
|
| Huntingtin Protein | 1 | 2018 | 145 | 0.130 |
Why?
|
| Genetic Engineering | 1 | 2018 | 117 | 0.130 |
Why?
|
| Galectins | 2 | 2013 | 8 | 0.130 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 161 | 0.130 |
Why?
|
| Mice | 4 | 2025 | 11004 | 0.130 |
Why?
|
| Biosensing Techniques | 1 | 2018 | 128 | 0.120 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2017 | 171 | 0.120 |
Why?
|
| Virus Replication | 3 | 2025 | 324 | 0.120 |
Why?
|
| Disease Progression | 3 | 2016 | 1176 | 0.120 |
Why?
|
| Receptors, Immunologic | 1 | 2016 | 179 | 0.110 |
Why?
|
| ADAM10 Protein | 1 | 2015 | 11 | 0.110 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2015 | 93 | 0.110 |
Why?
|
| Receptors, Virus | 1 | 2014 | 73 | 0.110 |
Why?
|
| Cell Adhesion Molecules | 1 | 2014 | 92 | 0.110 |
Why?
|
| B-Lymphocytes, Regulatory | 1 | 2014 | 5 | 0.110 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2013 | 3 | 0.110 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2013 | 8 | 0.110 |
Why?
|
| Leukocyte Common Antigens | 1 | 2013 | 59 | 0.100 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2014 | 137 | 0.100 |
Why?
|
| Dendritic Cells | 1 | 2017 | 529 | 0.100 |
Why?
|
| Immune Tolerance | 1 | 2014 | 181 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2014 | 161 | 0.100 |
Why?
|
| HIV-2 | 1 | 2012 | 23 | 0.100 |
Why?
|
| Endogenous Retroviruses | 1 | 2012 | 12 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2012 | 14 | 0.090 |
Why?
|
| Immunotherapy | 1 | 2014 | 265 | 0.090 |
Why?
|
| Interleukins | 1 | 2012 | 80 | 0.090 |
Why?
|
| Immunity, Cellular | 1 | 2012 | 178 | 0.090 |
Why?
|
| Cell Separation | 3 | 2017 | 146 | 0.080 |
Why?
|
| Morpholines | 2 | 2025 | 90 | 0.080 |
Why?
|
| Immunoglobulin A | 2 | 2020 | 98 | 0.080 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 1 | 2009 | 6 | 0.080 |
Why?
|
| Hepatitis C | 1 | 2010 | 152 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2015 | 2605 | 0.070 |
Why?
|
| Immunoglobulin G | 2 | 2020 | 463 | 0.070 |
Why?
|
| RNA, Viral | 2 | 2022 | 276 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2015 | 3318 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2022 | 189 | 0.060 |
Why?
|
| Biphenyl Compounds | 1 | 2025 | 33 | 0.060 |
Why?
|
| Benzamides | 1 | 2025 | 66 | 0.060 |
Why?
|
| Ionomycin | 1 | 2024 | 16 | 0.060 |
Why?
|
| Pyridones | 1 | 2025 | 42 | 0.060 |
Why?
|
| Antibodies | 2 | 2018 | 186 | 0.060 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2024 | 36 | 0.050 |
Why?
|
| Antigens | 1 | 2024 | 149 | 0.050 |
Why?
|
| Proteins | 1 | 2009 | 760 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2024 | 189 | 0.050 |
Why?
|
| Female | 6 | 2024 | 33382 | 0.050 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2014 | 62 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2024 | 266 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 343 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2022 | 130 | 0.040 |
Why?
|
| Phenotype | 1 | 2025 | 1223 | 0.040 |
Why?
|
| Antigens, Viral | 2 | 2012 | 137 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2020 | 115 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2020 | 134 | 0.040 |
Why?
|
| Male | 5 | 2024 | 30322 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2014 | 1597 | 0.040 |
Why?
|
| Coronavirus Infections | 1 | 2023 | 210 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2014 | 1999 | 0.040 |
Why?
|
| Protein Domains | 1 | 2020 | 154 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 116 | 0.040 |
Why?
|
| Adult | 3 | 2024 | 17134 | 0.040 |
Why?
|
| Protein Binding | 1 | 2024 | 1619 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 458 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2020 | 114 | 0.040 |
Why?
|
| Middle Aged | 3 | 2024 | 17921 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2024 | 531 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2020 | 587 | 0.040 |
Why?
|
| Gene Expression | 1 | 2022 | 851 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 329 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2020 | 495 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2018 | 110 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2018 | 63 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2018 | 130 | 0.030 |
Why?
|
| Endopeptidases | 1 | 2018 | 68 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2018 | 260 | 0.030 |
Why?
|
| Comorbidity | 1 | 2020 | 1119 | 0.030 |
Why?
|
| Plasmids | 1 | 2018 | 293 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2018 | 74 | 0.030 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2017 | 33 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 1622 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 239 | 0.030 |
Why?
|
| Lysosomes | 1 | 2017 | 169 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 627 | 0.030 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2017 | 212 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1561 | 0.030 |
Why?
|
| B7-H1 Antigen | 1 | 2016 | 59 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2014 | 22 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2016 | 234 | 0.030 |
Why?
|
| Massachusetts | 1 | 2020 | 2096 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 129 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2014 | 182 | 0.030 |
Why?
|
| Ligands | 1 | 2014 | 417 | 0.030 |
Why?
|
| vif Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 13 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 891 | 0.020 |
Why?
|
| Apoptosis | 1 | 2018 | 1095 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2012 | 48 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2014 | 240 | 0.020 |
Why?
|
| Virus Integration | 1 | 2012 | 32 | 0.020 |
Why?
|
| Cell Degranulation | 1 | 2012 | 20 | 0.020 |
Why?
|
| Gene Products, gag | 1 | 2012 | 67 | 0.020 |
Why?
|
| Perforin | 1 | 2012 | 31 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2014 | 290 | 0.020 |
Why?
|
| T-Box Domain Proteins | 1 | 2012 | 38 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 775 | 0.020 |
Why?
|
| Chromones | 1 | 2012 | 19 | 0.020 |
Why?
|
| Interleukin-7 | 1 | 2012 | 29 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2012 | 197 | 0.020 |
Why?
|
| CD28 Antigens | 1 | 2012 | 60 | 0.020 |
Why?
|
| Viral Envelope Proteins | 1 | 2012 | 103 | 0.020 |
Why?
|
| Interleukin-15 | 1 | 2012 | 25 | 0.020 |
Why?
|
| Virus Internalization | 1 | 2012 | 90 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 191 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2014 | 785 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2012 | 167 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 276 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2012 | 184 | 0.020 |
Why?
|
| HLA-A Antigens | 1 | 2010 | 9 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2014 | 1160 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2010 | 39 | 0.020 |
Why?
|
| HLA-A2 Antigen | 1 | 2010 | 64 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2012 | 291 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 2057 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2012 | 266 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2020 | 5696 | 0.020 |
Why?
|
| Cell-Free System | 1 | 2009 | 32 | 0.020 |
Why?
|
| tRNA Methyltransferases | 1 | 2009 | 10 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2009 | 49 | 0.020 |
Why?
|
| Inflammation | 1 | 2014 | 1163 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2009 | 542 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 3450 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 4781 | 0.020 |
Why?
|
| Liver | 1 | 2010 | 868 | 0.010 |
Why?
|